Zydus Cadila seeks emergency use nod for its Covid vaccine
  • 3 years ago
Zydus Cadila on Thursday announced that the company has applied for Emergency Use Authorization (EUA) to the office of Drug Controller General of India (DCGI) for ZyCoV-D - its Plasmid DNA Vaccine against Covid-19. The company conducted the largest clinical trial for its Covid-19 vaccine in India so far in over 50 centers. Watch top headlines.